This article examines how e-cigarettes containing synthetic nicotine compare to those with tobacco-derived nicotine in terms of reactive oxygen species (ROS) production. Understanding these differences is crucial for assessing health risks associated with different types of nicotine delivery systems.
The findings may influence regulatory decisions and public health policies, especially as synthetic nicotine products are not yet classified as tobacco products, creating a regulatory gap.